title: Interaction of the macrolide azithromycin with phospholipids. I. Inhibition of lysosomal phospholipase A1 activity.
abstract: Azithromycin, the first clinically developed dicationic macrolide antibiotic, displays an exceptional accumulation in lysosomes of cultured cells. In fibroblasts incubated with 50 mg/l (66.6 microM), it induces a distinct phospholipidosis as evidenced by biochemical and ultrastructural criteria, which strikingly resembles alterations described previously with gentamicin, a pentacationic aminoglycoside antibiotic which inhibits the lysosomal catabolism of phospholipids. We show that both drugs inhibit, in an equimolar manner, the activity of phospholipase A1 (assayed for phosphatidylcholine, included in negatively charged liposomes), in a way consistent with the model of 'charge neutralization' proposed already for gentamicin (Mingeot-Leclercq et al., 1988, Biochem. Pharmacol. 37, 591). Both drugs bind to negatively charged liposomes. Yet, in spite of this binding, azithromycin does not induce aggregation or fusion of negatively charged vesicles, under conditions in which gentamicin (or spermine, a fully hydrophilic polycation) causes a massive aggregation, and bis(beta-diethylaminoethylether)hexestrol (a dicationic amphiphile) causes fusion. The molecular interactions of azithromycin with acidic phospholipids are further examined in a companion paper.
authors.affiliation: Unité de Pharmacologie Cellulaire et Moléculaire, UCL 73.70, Bruxelles, Belgium. vanbambeke@facm.ucl.ac.be
authors.forename: F
authors.initials: F
authors.lastname: Van Bambeke
authors.forename: J P
authors.initials: JP
authors.lastname: Montenez
authors.forename: J
authors.initials: J
authors.lastname: Piret
authors.forename: P M
authors.initials: PM
authors.lastname: Tulkens
authors.forename: P J
authors.initials: PJ
authors.lastname: Courtoy
authors.forename: M P
authors.initials: MP
authors.lastname: Mingeot-Leclercq
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000494:pharmacology*; D017963:Azithromycin / Q000378:metabolism / Q000494:pharmacology*; D002478:Cells, Cultured; D004347:Drug Interactions; D005347:Fibroblasts; D005839:Gentamicins / Q000378:metabolism / Q000494:pharmacology*; D008081:Liposomes / Q000378:metabolism*; D010741:Phospholipases A / Q000378:metabolism*; D054466:Phospholipases A1; D010743:Phospholipids / Q000494:pharmacology*; D051381:Rats
chemical_list: D000900:Anti-Bacterial Agents; D005839:Gentamicins; D008081:Liposomes; D010743:Phospholipids; D017963:Azithromycin; D010741:Phospholipases A; D054466:Phospholipases A1